Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
dnaJ Peptide in Rheumatoid Arthritis
NCT00000435Phase 2Completed
- Sponsor
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
- Start
- Sep 1999
- Modality
- Prophylactic Vaccines, Therapeutic Vaccines, Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of dnaJP1 in rheumatoid arthritis (RA), sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases. Started Sep 1999; status: completed.
02
Drugs
dnaJP1
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00000435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000435.